Attached files
file | filename |
---|---|
EX-21.1 - EXHIBIT 21.1 - IVERIC bio, Inc. | isee12312019exhibit211subs.htm |
EX-10.34 - EXHIBIT 10.34 - IVERIC bio, Inc. | davidcarrollletter1219.htm |
EX-32.1 - EXHIBIT 32.1 - IVERIC bio, Inc. | isee12312019exhibit321.htm |
EX-31.2 - EXHIBIT 31.2 - IVERIC bio, Inc. | isee12312019exhibit312.htm |
EX-31.1 - EXHIBIT 31.1 - IVERIC bio, Inc. | isee12312019exhibit311.htm |
EX-23.1 - EXHIBIT 23.1 - IVERIC bio, Inc. | isee12312019exhibit231.htm |
EX-14.1 - EXHIBIT 14.1 - IVERIC bio, Inc. | ivericbiocodeofbusinessc.htm |
EX-10.36 - EXHIBIT 10.36 - IVERIC bio, Inc. | keithwestbyletter1219.htm |
EX-4.2 - EXHIBIT 4.2 - IVERIC bio, Inc. | iseestockcertificate.htm |
EX-4.1 - EXHIBIT 4.1 - IVERIC bio, Inc. | exhibit41.htm |
10-K - 10-K - IVERIC bio, Inc. | iveric1231201910-k.htm |
Exhibit 32.2
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report on Form 10-K of IVERIC bio, Inc. (the "Company") for the fiscal year ended December 31, 2019 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), the undersigned, David F. Carroll, Chief Financial Officer of the Company, hereby certifies, pursuant to Rule 13a-14(b) and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:
(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: February 27, 2020 | By: | /s/ David F. Carroll | ||
David F. Carroll Chief Financial Officer (Principal Financial Officer) |